Deniz ErdemirDeniz Erdemir is a Principal Scientist at Bristol-Myers Squibb (BMS). Dr Erdemir's research focus lies at the drug substance/drug product interface with emphasis on crystal polymorphism and design of materials via particle engineering to enable robus drug products. She has published twelve papers and she is the inventor on two US patents. Read More Read Less